IL6 and lymphoma: This prospective cohort study evaluated whether dynamic changes in serum IL-6, TNF-<i>α</i>, and β2-microglobulin (β2-MG) can serve as early predictors of relapse.<h4>Methods</h4>A total of 260 patients with pathologically confirmed lymphoma who completed standard chemotherapy were enrolled and followed longitudinally.